CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Other events
- 4 Grant or award Chief Operating Officer acquired 3,310 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 2,592 shares (grant or award)
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 46 · 909 filings